Table 2. Characteristics of 18 studies investigating MACE in the meta-analysis.
| Study | Year | Design | Stent | Age | Male | Total Patients | DM patients | FU | OR(95%CI) |
| Briguori M(S21) | 2005 | Retrospective | SES | 65.9 | 781(77.2) | 1012 | 222 | 5 y | 1.45(0.62–3.56) |
| Cosgrave J(S22) | 2005 | Prospective | SES-PES | 62.3 | 465(87.9) | 529 | 127 | 9 m | 2.06(1.37–3.10) |
| Fath-Ordoubadi F (S23) | 2012 | RCT | DES | 63.1 | 1268(77.3) | 1640 | 462 | 2 y | 1.54(1.11–2.213) |
| Fujiwara K(S24) | 2002 | Retrospective | BMS | 64.2 | 268(83.0) | 323 | 214 | 6 m | 1.99(1.23–3.22) |
| Gao RL(S25) | 2008 | Prospective | DES | 60 | 967 (81.3) | 1189 | 271 | 9 m | 2.149(1.085–4.256) |
| Gurvitch R(S26) | 2010 | Prospective | DES | 62.6 | 404(71.6) | 564 | 83 | 12 m | 1.75(0.96–3.20) |
| Hoffmann R(S27) | 2007 | Retrospective | B/D | 60 | 595(80.1) | 734 | 164 | 27.5 m | 2.14(1.48–3.07) |
| Ijsselmuiden AJJ(S7) | 2003 | RCT | BMS | 61 | 324(81.0) | 400 | 32 | 6 m | 2.22(1.10–4.40) |
| Kralev S(S28) | 2009 | Prospective | BMS | 65 | 291(73.9) | 394 | 95 | 6 m | 1.42(0.86–2.35) |
| Kuchulakanti PK(S29) | 2005 | Prospective | SES | 64.1 | 897(63.8) | 1407 | 496 | 6 m | 2.3(0.9–5.8) |
| Lee MS(S30) | 2008 | Retrospective | DES | 68 | 651(73.4) | 887 | 244 | 12 m | 2.10(1.06–4.16) |
| Lee SR(S31) | 2008 | Prospective | SES | 62 | 1123(72.8) | 1541 | 380 | 6 m | 1.167(0.680–2.004) |
| Nakamura M(S32) | 2010 | Prospective | SES | 66.2 | 641(72.1) | 889 | 889 | 3 y | 1.535(1.034–2.279) |
| Novack V(S33) | 2009 | Prospective | DES | 63.3 | 494(68.4) | 722 | 256 | 12 m | 1.00(0.71–1.39) |
| Ogita M(S34) | 2011 | Retrospective | BMS | 64.7 | 628(63.9) | 983 | 271 | 2214 d | 1.03(0.65–1.64) |
| Patsa C(S35) | 2011 | Prospective | DES | 61.8 | 423(82.7) | 511 | 173 | 20 m | 2.01(0.99–4.11) |
| Yan BP(S36) | 2011 | Prospective | DES | 64.6 | 6875(74.7) | 9204 | 2209 | 12 m | 1.3(1.1–1.54) |
| Zahn R(S37) | 2010 | RCT | SES | 64.8 | 8826(75.5) | 10894 | 3197 | 6.4 m | 1.48(1.16–1.90) |